Gelfand JM - Search Results

1

Risk of myocardial infarction in patients with psoriasis.

Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Gelfand JM, et al. JAMA. 2006 Oct 11;296(14):1735-41. doi: 10.1001/jama.296.14.1735. JAMA. 2006. PMID: 17032986

2

Surrogate endpoints for the treatment of venous leg ulcers.

Gelfand JM, Hoffstad O, Margolis DJ. Gelfand JM, et al. J Invest Dermatol. 2002 Dec;119(6):1420-5. doi: 10.1046/j.1523-1747.2002.19629.x. J Invest Dermatol. 2002. PMID: 12485449 Free article.

3

Surrogate end points for the treatment of diabetic neuropathic foot ulcers.

Margolis DJ, Gelfand JM, Hoffstad O, Berlin JA. Margolis DJ, et al. Among authors: gelfand jm. Diabetes Care. 2003 Jun;26(6):1696-700. doi: 10.2337/diacare.26.6.1696. Diabetes Care. 2003. PMID: 12766096

4

Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom.

Gelfand JM, Berlin J, Van Voorhees A, Margolis DJ. Gelfand JM, et al. Arch Dermatol. 2003 Nov;139(11):1425-9. doi: 10.1001/archderm.139.11.1425. Arch Dermatol. 2003. PMID: 14623702

5

Determinants of quality of life in patients with psoriasis: a study from the US population.

Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ. Gelfand JM, et al. J Am Acad Dermatol. 2004 Nov;51(5):704-8. doi: 10.1016/j.jaad.2004.04.014. J Am Acad Dermatol. 2004. PMID: 15523347

6

The prevalence of psoriasis in African Americans: results from a population-based study.

Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, Rolstad T, Margolis DJ. Gelfand JM, et al. J Am Acad Dermatol. 2005 Jan;52(1):23-6. doi: 10.1016/j.jaad.2004.07.045. J Am Acad Dermatol. 2005. PMID: 15627076

7

Increased risk for demyelinating diseases in patients with inflammatory bowel disease.

Gupta G, Gelfand JM, Lewis JD. Gupta G, et al. Among authors: gelfand jm. Gastroenterology. 2005 Sep;129(3):819-26. doi: 10.1053/j.gastro.2005.06.022. Gastroenterology. 2005. PMID: 16143121

8

The psychometric properties of the psoriasis disability index in United States patients.

Nijsten T, Whalley D, Gelfand J, Margolis D, McKenna SP, Stern RS. Nijsten T, et al. J Invest Dermatol. 2005 Oct;125(4):665-72. doi: 10.1111/j.0022-202X.2005.23775.x. J Invest Dermatol. 2005. PMID: 16185264 Free article.

9

Epidemiology of psoriatic arthritis in the population of the United States.

Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T. Gelfand JM, et al. J Am Acad Dermatol. 2005 Oct;53(4):573. doi: 10.1016/j.jaad.2005.03.046. J Am Acad Dermatol. 2005. PMID: 16198775

10

Prevalence and treatment of psoriasis in the United Kingdom: a population-based study.

Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Gelfand JM, et al. Arch Dermatol. 2005 Dec;141(12):1537-41. doi: 10.1001/archderm.141.12.1537. Arch Dermatol. 2005. PMID: 16365254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

469 results

Search Page

Filters